Javascript must be enabled to continue!
695Gene and environmental factors for liver fibrosis among Japanese general population with NAFLD
View through CrossRef
Abstract
Background
A part of nonalcoholic fatty liver disease (NAFLD) develops nonalcoholic steatohepatitis (NASH), liver cirrhosis and hepatocellular carcinoma. Metabolic syndrome is involved in their development, and hepatic fibrosis plays an important role in their pathogenesis. Patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene encode proteins on hepatic lipid metabolism regulation, and PNPLA3 gene polymorphism is associated with the development and progression of NAFLD. To investigate the gene and environmental factors, and their interaction for liver fibrosis, we conducted a prospective study among Japanese general population with NAFLD.
Methods
The subjects were 295 general residents who participated as a part of the Japan Multi-Institutional Collaborative Cohort (J-MICC) study in Kagoshima, Japan, and were followed for 5 years. NAFLD was defined as fatty liver using abdominal ultrasonography. PNPLA3 C/G polymorphism (rs738409) was analysed using TaqMan PCR. Hepatic fibrosis was defined using FIB 4 index (≥1.3). Logistic regression model was used to estimate the odds ratios (ORs) after adjusted for confounding factors.
Results
Mean age was 55.1 years and liver fibrosis was observed at 73.2% among NAFLD subjects. No environmental factors were associated with liver fibrosis, and PNPLA3 GG genotype was not associated with liver fibrosis, too. However, the ORs of CC & CG, and GG genotypes for dyslipidemia was respectively 0.45 (0.19-1.04) and 11.9 (1.81-78.4), and their interaction was significant (p = 0.01).
Conclusions
The interaction between PNPLA3 GG gene polymorphism and dyslipidemia for liver fibrosis was observed.
Key messages
Genetic susceptibility with dyslipidemia may be involved in liver fibrosis of NAFLD.
Title: 695Gene and environmental factors for liver fibrosis among Japanese general population with NAFLD
Description:
Abstract
Background
A part of nonalcoholic fatty liver disease (NAFLD) develops nonalcoholic steatohepatitis (NASH), liver cirrhosis and hepatocellular carcinoma.
Metabolic syndrome is involved in their development, and hepatic fibrosis plays an important role in their pathogenesis.
Patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene encode proteins on hepatic lipid metabolism regulation, and PNPLA3 gene polymorphism is associated with the development and progression of NAFLD.
To investigate the gene and environmental factors, and their interaction for liver fibrosis, we conducted a prospective study among Japanese general population with NAFLD.
Methods
The subjects were 295 general residents who participated as a part of the Japan Multi-Institutional Collaborative Cohort (J-MICC) study in Kagoshima, Japan, and were followed for 5 years.
NAFLD was defined as fatty liver using abdominal ultrasonography.
PNPLA3 C/G polymorphism (rs738409) was analysed using TaqMan PCR.
Hepatic fibrosis was defined using FIB 4 index (≥1.
3).
Logistic regression model was used to estimate the odds ratios (ORs) after adjusted for confounding factors.
Results
Mean age was 55.
1 years and liver fibrosis was observed at 73.
2% among NAFLD subjects.
No environmental factors were associated with liver fibrosis, and PNPLA3 GG genotype was not associated with liver fibrosis, too.
However, the ORs of CC & CG, and GG genotypes for dyslipidemia was respectively 0.
45 (0.
19-1.
04) and 11.
9 (1.
81-78.
4), and their interaction was significant (p = 0.
01).
Conclusions
The interaction between PNPLA3 GG gene polymorphism and dyslipidemia for liver fibrosis was observed.
Key messages
Genetic susceptibility with dyslipidemia may be involved in liver fibrosis of NAFLD.
Related Results
Association of Lipid Profile Abnormalities with NAFLD Severity in Patients with Metabolic Syndrome
Association of Lipid Profile Abnormalities with NAFLD Severity in Patients with Metabolic Syndrome
Background: Nonalcoholic fatty liver disease (NAFLD) is becoming a significant global health issue, and it is frequently associated with metabolic conditions, including hypertensio...
Metabolic dysfunction–associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
Metabolic dysfunction–associated fatty liver disease indicates more hepatic fibrosis than nonalcoholic fatty liver disease
The term metabolic dysfunction–associated fatty liver disease (MAFLD) has been proposed based on a redefinition of the nonalcoholic fatty liver disease (NAFLD) criteria. Our study ...
Clinical research for the significance of inflammatory factors and adiponectin in type 2 diabetes complicated with non-alcoholic fatty liver disease
Clinical research for the significance of inflammatory factors and adiponectin in type 2 diabetes complicated with non-alcoholic fatty liver disease
Objective
To investigate the clinical significance of inflammatory factors and adiponectin in type 2 diabetes milletus complicated with non-alcoholic fatty liver ...
Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients
Correlational study on the levels of 25-hydroxyvitamin D and non-alcoholic fatty liver disease in type 2 diabetic patients
Abstract
Background
It is widely acknowledged that nonalcoholic fatty liver disease(NAFLD) and type 2 diabetes mellitus(T2DM) are all chronic metabolic diseases.The object...
Cumulative exposure to AHA Life's Essential 8 is associated with nonalcoholic fatty liver disease: a large cohort study
Cumulative exposure to AHA Life's Essential 8 is associated with nonalcoholic fatty liver disease: a large cohort study
Abstract
Background and Aim
We aimed to explore the associations of baseline and cumulative cardiovascular health with nonalcoholic fatty liver dise...
Decreased Serum zinc, selenium, and vitamin E as possible risk factors of hepatic fibrosis in non-alcoholic fatty liver disease
Decreased Serum zinc, selenium, and vitamin E as possible risk factors of hepatic fibrosis in non-alcoholic fatty liver disease
Backgrounds The incidence of non-alcoholic fatty liver disease (NAFLD) has been significantly growing in recent years. Although the pathophysiology of fibrosis progression in NAFLD...
Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD)
Vigorous physical activity provides protection against all‐cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD)
SummaryBackgroundMortality benefits of vigorous leisure time physical activity (LTPA) among adults with NAFLD is not known.AimTo investigate association between LTPA and reduction ...
Screening for the Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Among Patients With Prediabetes and Type 2 Diabetes: A Comparison of Three Screening Systems
Screening for the Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Among Patients With Prediabetes and Type 2 Diabetes: A Comparison of Three Screening Systems
Purpose: To screen for the prevalence and severity of nonalcoholic fatty liver disease (NAFLD) and degree of liver fibrosis in patients with prediabetes and Type 2 diabetes. Additi...

